Literature DB >> 1613816

Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia.

A Nordberg1, I Alafuzoff, B Winblad.   

Abstract

Different effects of normal aging on muscarinic and nicotinic receptor subtypes were observed in postmortem brain tissue from different regions of the human brain. A significant decrease in M1 and M2 receptors was found in cerebral cortex, while the M1 and especially the M2 receptors increased with age in the thalamus. A similar pattern of changes was also observed when using (-)3H-nicotine as ligand for nicotinic receptors in the cortex and thalamus. No significant changes in nicotinic receptor binding were observed with age in the cortex or thalamus when using 3H-acetylcholine as ligand. Nicotinic and muscarinic receptors in the brain are not equally affected in dementia disorders. A marked loss of high affinity nicotinic receptors was observed in cortical tissue from patients with Alzheimer's disease and with multi-infarct dementia (MID). The muscarinic receptors were (both M1 and M2) increased in Alzheimer cortical tissue while they were decreased in MID.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1613816     DOI: 10.1002/jnr.490310115

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  51 in total

1.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Executive and social behaviors under nicotinic receptor regulation.

Authors:  Sylvie Granon; Philippe Faure; Jean-Pierre Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-22       Impact factor: 11.205

Review 3.  Alzheimer's disease amyloid beta-protein and synaptic function.

Authors:  Tomas Ondrejcak; Igor Klyubin; Neng-Wei Hu; Andrew E Barry; William K Cullen; Michael J Rowan
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

4.  Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD.

Authors:  Mattis B Wigestrand; Yann S Mineur; Christopher J Heath; Frode Fonnum; Marina R Picciotto; Sven Ivar Walaas
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

Review 5.  Cognitive impairment in acquired brain injury: a predictor of rehabilitation outcomes and an opportunity for novel interventions.

Authors:  Ellen Whyte; Elizabeth Skidmore; Howard Aizenstein; Joseph Ricker; Meryl Butters
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

6.  PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.

Authors:  Ahmadul Kadir; Ove Almkvist; Anders Wall; Bengt Långström; Agneta Nordberg
Journal:  Psychopharmacology (Berl)       Date:  2006-07-11       Impact factor: 4.530

7.  In vivo metabolic studies of the trans-(R,R) isomer of radioiodinated IQNP: a new ligand with high affinity for the M1 muscarinic-cholinergic receptor.

Authors:  D W McPherson; C R Lambert; F F Knapp
Journal:  Eur J Nucl Med       Date:  1994-12

Review 8.  M1 muscarinic receptor for the development of auditory cortical function.

Authors:  Karalee K Shideler; Jun Yan
Journal:  Mol Brain       Date:  2010-10-22       Impact factor: 4.041

9.  The developing cholinergic system as target for environmental toxicants, nicotine and polychlorinated biphenyls (PCBs): implications for neurotoxicological processes in mice.

Authors:  P Eriksson; E Ankarberg; H Viberg; A Fredriksson
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

10.  Functional and neurobiological similarities of aging in monkeys and humans.

Authors:  M L Voytko
Journal:  Age (Omaha)       Date:  1997-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.